These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17717257)

  • 21. Sugammadex: A Review of Neuromuscular Blockade Reversal.
    Keating GM
    Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel approach to reversal of neuromuscular blockade.
    Della Rocca G; Pompei L
    Minerva Anestesiol; 2009 May; 75(5):349-51. PubMed ID: 19412157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of sugammadex for the reversal of vecuronium-induced neuromuscular block following intracranial surgery.
    Karwacki Z; Niewiadomski S; Rzaska M
    Anaesthesiol Intensive Ther; 2015; 47(4):297-302. PubMed ID: 26401735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
    Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
    Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On extubation, residual curarization, and their circumstances].
    Ortiz-Gómez JR; Fabregat-López J
    Rev Esp Anestesiol Reanim; 2009; 56(6):335-8. PubMed ID: 19725339
    [No Abstract]   [Full Text] [Related]  

  • 28. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of Sugammadex in Patients With Obesity: A Pooled Analysis.
    Monk TG; Rietbergen H; Woo T; Fennema H
    Am J Ther; 2017; 24(5):e507-e516. PubMed ID: 26398716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sugammadex reversal of neuromuscular blockade for thymectomy in a patient with myasthenia gravis].
    Monsalve Naharro JA; Gerónimo Pardo M; Ortiz Sánchez VE; Pérez Valdivieso JM
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):624-5. PubMed ID: 22263413
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacology of sugammadex].
    Meistelman C; Fuchs-Buder T
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S51-6. PubMed ID: 19887278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on sugammadex sodium.
    Welliver M; Cheek D
    AANA J; 2009 Jun; 77(3):219-28. PubMed ID: 19645172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Use of Sugammadex in a Patient With Guillain-Barre Syndrome: A Case Report.
    Tezcan B; Bölükbaşi D; Kazanci D; Turan S; Suer Kaya G; Özgök A
    A A Case Rep; 2017 Apr; 8(8):200-202. PubMed ID: 28151766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.
    Carron M; Zarantonello F; Tellaroli P; Ori C
    J Clin Anesth; 2016 Dec; 35():1-12. PubMed ID: 27871504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sugammadex rapidly reverses moderate rocuronium- or vecuronium-induced neuromuscular block during sevoflurane anaesthesia: a dose-response relationship.
    Pühringer FK; Gordon M; Demeyer I; Sparr HJ; Ingimarsson J; Klarin B; van Duijnhoven W; Heeringa M
    Br J Anaesth; 2010 Nov; 105(5):610-9. PubMed ID: 20876699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
    Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
    Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo animal studies with sugammadex.
    Booij LH; van Egmond J; Driessen JJ; de Boer HD
    Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sugammadex: the first selective binding reversal agent for neuromuscular block.
    Kovac AL
    J Clin Anesth; 2009 Sep; 21(6):444-53. PubMed ID: 19833281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do we really need sugammadex as an antagonist of muscle relaxants in anesthesia?
    Meistelman C; Donati F
    Curr Opin Anaesthesiol; 2016 Aug; 29(4):462-7. PubMed ID: 27168088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.